Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Accumulated Depreciation & Amortization (2016 - 2025)

Marimed (MRMD) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $27.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 25.35% to $27.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.1 million through Dec 2025, up 25.35% year-over-year, with the annual reading at $27.1 million for FY2025, 25.35% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $27.1 million at Marimed, up from $25.5 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $27.1 million in Q4 2025, with the low at $462000.0 in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $14.0 million, with a median of $12.8 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization fell 4.55% in 2021, then skyrocketed 1553.03% in 2022.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $7.0 million in 2021, then soared by 47.02% to $10.2 million in 2022, then skyrocketed by 45.89% to $14.9 million in 2023, then soared by 45.11% to $21.6 million in 2024, then grew by 25.35% to $27.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $27.1 million, $25.5 million, and $23.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.